Question Bank › Self-authored recovery

Self-authored recovery

Self-authored recovery: the company got itself out of the ditch, and management can name what it fixed

Calls Tested
499
Answered YES
20
Hit Rate
4%
rare by design

Fate Therapeutics, Inc. (FATE) — this company's answers

NO on the Q3 2016 call 2016-11-07 C
The model's full reasoning — Q3 2016 call → NOWe need to answer YES or NO based only on the transcript. The question asks: Does management convey that the company is emerging from a genuinely weak or difficult stretch of its own — and attribute the improvement now underway primarily to specific things the company itself did or built, rather than to outside conditions getting better? We need to see if management acknowledges a real bad stretch and points to current-period evidence of improvement, and attributes that improvement to its own actions. From the transcript: The company is Fate Therapeutics. They discuss progress in clinical programs, not necessarily financial performance. The call is about Q3 2016 results. They talk about ProTmune clinical trial, FATE-NK100 IND filing, ToleraCyte, iPSC platform. They mention "enrollment is now open under this enhanced protocol" after a delay due to protocol amendment. They say "we have made substantial progress" and "intensified our clinical commitment." They talk about receiving FDA fast-track and orphan designations. They also mention "while this has initially delayed enrollment in the Phase I stage, enrollment is now open under this enhanced protocol." So there was a delay, but they are moving forward. The financial results: net loss increased from $6.9M to $8.7M. Revenue flat at $1M. They don't really mention a "weak or difficult stretch" in terms of business performance. They don't talk about declining sales or losses as a problem. They are a biotech with no products, so losses are expected. The transcript is mostly about clinical progress. The question is about "emerging from a genuinely WEAK OR DIFFICULT STRETCH OF ITS OWN" - did they have a bad stretch? They mention a delay in enrollment due to protocol amendment, but they don't frame it as a difficult period. They talk about "initial delayed enrollment" but that's not a bad stretch of business. They don't attribute improvement to specific company actions that are now producing results. They talk about progress and milestones, but the improvement is in clinical development, not necessarily in financial performance. Also, the company's own actions? They mention amending protocol to blind study, expanding eligibility, etc. That was their own decision, but is that described as a turn from a bad period? No.

← Back to the full FATE analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management convey that the company is emerging from a genuinely WEAK OR DIFFICULT STRETCH OF ITS OWN — and attribute the improvement now underway PRIMARILY TO SPECIFIC THINGS THE COMPANY ITSELF DID OR BUILT, rather than to outside conditions getting better? Answer YES when management's own words convey BOTH halves of this one phenomenon, in whatever form fits the business: (1) A REAL BAD STRETCH, ACKNOWLEDGED, WITH THE TURN ALREADY VISIBLE. It is evident from management's own account that the company recently went through a genuinely poor period — declining or depressed sales, losses, an operational failure, lost customers, a product or strategy that was not working, or results management itself treats as unacceptable — and management points to real, current-period evidence that the business is now improving: actual recent orders, customers, volumes, activity, output, or profitability that has already begun to recover or grow. The improvement must be described as already happening in the business now, not merely forecast, hoped for, or promised. (2) THE COMPANY ITSELF IS THE STATED CAUSE OF THE TURN. When management explains WHY things are getting better, the explanation rests chiefly on identifiable actions or assets of the company's own making — for example: a product, offering, or capability the company fixed, finished, or introduced that customers are now taking up; a change in leadership, organization, salesforce, pricing, quality, or operations the company executed that is now producing; problem customers, contracts, products, or costs the company removed so the remaining business now performs; a facility, capacity, or capability the company built or repaired that is now working — with at least one such driver described concretely enough that a reader can tell what the company actually did and how it connects to the improvement now showing. Management should convey, directly or plainly in substance, that these self-made drivers remain in force — still ramping, still spreading through the business, or with more of their effect ahead — so the recovery reads as the early stretch of something the company controls rather than a finished bounce. Answer NO if the company never went through a meaningfully difficult stretch and is simply continuing to perform well. NO if conditions are still deteriorating with improvement only promised, planned, or expected. NO if management attributes the improvement mainly to outside forces — market recovery, industry demand returning, commodity or price moves, weather, currency, restocking, a competitor's stumble, or macro conditions easing — with the company's own actions secondary. NO if the self-help story consists only of generic cost cutting, belt-tightening, or restructuring language with no identifiable thing the company fixed, built, or changed that is now producing. NO if the improvement rests chiefly on one-time items such as asset sales, settlements, or accounting effects. NO if the recovery narrative appears only in an analyst's question or characterization that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
SFIX Stitch Fix, Inc. Q3 2024 2024-06-04 C+
NC NACCO Industries, Inc. Q1 2024 2024-05-05 C+
KOPN Kopin Corporation Q4 2023 2024-03-14 C+
GPRE Green Plains Inc. Q4 2023 2024-02-07 F
QTRX Quanterix Corporation Q3 2023 2023-11-07 B
ALL The Allstate Corporation Q3 2023 2023-11-02 C+
OPAD Offerpad Solutions Inc. Q3 2023 2023-11-01 C
THS TreeHouse Foods, Inc. Q1 2023 2023-05-08 B+
INGN Inogen, Inc. Q1 2023 2023-05-05 F
SWK Stanley Black & Decker, Inc. Q1 2023 2023-05-04 D
BGS B&G Foods, Inc. Q4 2022 2023-02-28 C+
PRPO Precipio, Inc. Q3 2018 2018-11-19 D
CLMT Calumet Specialty Products Partners, L.P Q1 2018 2018-05-16 C+
FOSL Fossil Group, Inc. Q1 2018 2018-05-08 C
AVT Avnet, Inc. Q2 2018 2018-01-25 B
PII Polaris Inc. Q3 2017 2017-10-24 C+
CAG Conagra Brands, Inc. Q2 2017 2016-12-22 C+
TGI Triumph Group, Inc. Q2 2017 2016-11-03 C+
MAT Mattel, Inc. Q3 2016 2016-10-19 C
GIS General Mills, Inc. Q4 2016 2016-06-29 B+

How the model reasoned

MAT · Q3 2016 → YESThe question is: Does management convey that the company is emerging from a genuinely WEAK OR DIFFICULT STRETCH OF ITS OWN — and attribute the improvement now underway PRIMARILY TO SPECIFIC THINGS THE...NO The transcript shows management acknowledging revenue challenges this year (Disney Princess loss, Monster High, FX, mix) and noting progress like positive POS excluding Disney and shipping alignment. However, it does not clearly convey a completed "genuinely weak or difficult stretch" from which they are emerging with a visible turnaround already underway.
NC · Q1 2024 → YESThe question is: Does management convey that the company is emerging from a genuinely WEAK OR DIFFICULT STRETCH OF ITS OWN — and attribute the improvement now underway PRIMARILY TO SPECIFIC THINGS THE...
KOPN · Q4 2023 → YESThe question is: Does management convey that the company is emerging from a genuinely WEAK OR DIFFICULT STRETCH OF ITS OWN — and attribute the improvement now underway PRIMARILY TO SPECIFIC THINGS THE...

More from the question bank

Undersized for what it has already been handGrowing out of the old selfThe company is outgrowing its own explanatioWinning is getting easierMid-period crossingsRationing itself to growAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.